Advertisement

Taurine 7 pp 265-271 | Cite as

Dietary Taurine Attenuates Dextran Sulfate Sodium (DSS)-induced Experimental Colitis in Mice

  • Makoto Shimizu
  • Zhaohui Zhao
  • Yoko Ishimoto
  • Hideo Satsu
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)

Abstract

Effects of dietary taurine on the experimental colitis induced by dextran sulfate sodium (DSS) were studied. C57BL/6 mice administrated taurine or placebo for 5 days were given 3% DSS to induce acute. The colitis was as-sessed using indices such as diarrhea/bleeding scores, colon length change, histological score and tissue myeloperoxidase (MPO) activity. Further, tis-sue mRNA levels of interleukin (IL)-1β, tumor necrosis factor (TNF)-α and macrophage inflammatory protein (MIP)-2, were determined by real-time PCR. Taurine supplementation significantly attenuated the severity of diarrhea, colon shortening, histological score, MPO activity elevation and abnormal MIP-2 gene expression, indicating that taurine prevents DSS-induced colitis. Taurine also inhibited the TNF-α-induced secretion of IL-8 (a hu-man homologue of MIP-2) from human intestinal epithelial Caco-2 cells. Inhibition of chemokine secretion from intestinal cells may be involved in the mechanisms underlying the cytoprotective function of taurine in the intestinal epithelium.

Keywords

Dextran Sulfate Sodium Taurine Supplementation Taurine Uptake Dietary Taurine Taurine Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238–249PubMedGoogle Scholar
  2. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflamma-tory bowel disease. Gastroenterology 109:1344–1367PubMedCrossRefGoogle Scholar
  3. Ishizuka K, Kanayama A, Satsu H, Miyamoto Y, Furihata K, Shimizu M (2000) Identifica-tion of a taurine transport inhibitory substance in sesame seeds. Biosci Biotechnol Bio-Chem 64: 1166–1172CrossRefGoogle Scholar
  4. Ishizuka K, Miyamoto Y, Satsu H, Sato R, Shimizu M (2002) Characteristics of lysophosp-hatidylcholine in its inhibition of taurine uptake by human intestinal Caco-2 cells. Biosci Biotechnol Biochem 66:730–736PubMedCrossRefGoogle Scholar
  5. Kanayama A, Inoue J, SugitaKonishi Y, Shimizu M, Miyamoto Y (2002) Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NFkappa B activation. J Biol Chem 277:24049–24056PubMedCrossRefGoogle Scholar
  6. Kim H, Jeon H, Kong H, Yang Y, Choi B, Kim YM, Neckers L, Jung Y (2006) A molecular mechanism for the anti-inflammatory effect of taurineconjugated 5-aminosalicylic acid in inflamed colon. Mol Pharmacol 69:1405–1412PubMedCrossRefGoogle Scholar
  7. Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflamma-tion based on myeloperoxidase activity. Assessment of inflammation in rat and hams-ter models. Gastroenterology 87:1344–1350Google Scholar
  8. Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, Nishi T, Asada M, Kawasaki K, Fukui T, Yoshizawa H, Ohashi S, Inoue S, Kawanami C, Hiai H, Tabata Y, Chiba T (2005) Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 128:975–986PubMedCrossRefGoogle Scholar
  9. Mochizuki T, Satsu H, Shimizu M (2002) Tumor necrosis factor alpha stimulates 0 taurine uptake and transporter gene expression in human intestinal Caco-2 cells. FEBS Lett 517:92–96PubMedCrossRefGoogle Scholar
  10. Mochizuki T, Satsu H, Shimizu M (2005) Signaling pathways involved in tumor necrosis factor alpha-induced up-regulation of the taurine transporter in Caco-2 cells. FEBS Lett 579: 3069–3074PubMedCrossRefGoogle Scholar
  11. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702PubMedGoogle Scholar
  12. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for groupwise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e3–e6CrossRefGoogle Scholar
  13. Satsu H, Ishimoto Y, Nakano T, Mochizuki T, Iwanaga T, Shimizu M (2006) Induction by activated macrophagelike THP1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factoralpha. Exp Cell Res 312:3909–3019PubMedCrossRefGoogle Scholar
  14. Satsu H, Miyamoto Y, Shimizu M (1999) Hypertonicity stimulates taurine uptake and transporter gene expression in Caco-2 cells. Biochim Biophys Acta 1419:89–96PubMedCrossRefGoogle Scholar
  15. Satsu H, Watanabe H, Arai S, Shimizu M (1997) Characterization and regulation of taurine transport in Caco-2, human intestinal cells. J Biochem (Tokyo) 121:108–127Google Scholar
  16. SchullerLevis GB, Park E (2004) Taurine and its chloramine: modulators of immunity. Neu-rochem Res 29:117–126Google Scholar
  17. Son MW, Ko JI, Doh HM, Kim WB, Park TS, Shim MJ, Kim BK (1998) Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch Pharm Res 21:531–536PubMedCrossRefGoogle Scholar
  18. Zhao ZH, Hyun JS, Satsu H, Kakuta S, Shimizu M (2006) Oral exposure to cadmium chlo-ride triggers an acute inflammatory response in the intestines of mice, initiated by the overexpression of tissue macrophage inflammatory protein2 mRNA. Toxicology Let-ters 164:144–154CrossRefGoogle Scholar
  19. Zhao Z, Satsu H, Fujisawa M, Hori M, Ishimoto Y, Totsuka M, Nambu A, Kakuta S, Ozaki H, Shimizu M (2008) Attenuation by dietary taurine of dextran sulfate sodium-induced colitis in mice and of THP-1-induced damage to intestinal Caco-2 cell monolayers. Amino Acids 35(1):217-24.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Makoto Shimizu
    • 1
  • Zhaohui Zhao
  • Yoko Ishimoto
  • Hideo Satsu
  1. 1.Department of Applied Biological ChemistryThe University of TokyoTokyoJapan

Personalised recommendations